- Investing Ideas
- /
- Semiconductors Healthcare Sector
Semiconductors Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Palvella Therapeutics
Market Cap: US$254.8m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.
PVLA
US$21.70
7D
-1.7%
1Y
n/a
ProKidney
Market Cap: US$254.2m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$0.77
7D
20.4%
1Y
-80.3%
Terns Pharmaceuticals
Market Cap: US$253.3m
A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.
TERN
US$2.78
7D
-8.1%
1Y
-53.6%
Tristel
Market Cap: UK£189.6m
Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
TSTL
UK£3.98
7D
6.0%
1Y
-9.7%
Cerus
Market Cap: US$250.4m
Operates as a biomedical products company.
CERS
US$1.25
7D
-3.8%
1Y
-38.4%
ZimVie
Market Cap: US$248.8m
Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.
ZIMV
US$8.72
7D
-2.0%
1Y
-47.7%
Monte Rosa Therapeutics
Market Cap: US$248.5m
A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.
GLUE
US$3.70
7D
-3.9%
1Y
-29.3%
Tvardi Therapeutics
Market Cap: US$248.3m
Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.
TVRD
US$26.35
7D
1.3%
1Y
n/a
Gossamer Bio
Market Cap: US$247.7m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$1.01
7D
-7.8%
1Y
36.1%
Allogene Therapeutics
Market Cap: US$247.2m
A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.
ALLO
US$0.95
7D
-20.6%
1Y
-68.0%
Alumis
Market Cap: US$242.7m
A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.
ALMS
US$4.51
7D
-5.8%
1Y
n/a
Foghorn Therapeutics
Market Cap: US$240.8m
A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.
FHTX
US$4.11
7D
3.0%
1Y
-22.3%
Creative Medical Technology Holdings
Market Cap: US$234.7m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$2.04
7D
5.7%
1Y
-53.6%
Vanda Pharmaceuticals
Market Cap: US$234.6m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$3.92
7D
-10.5%
1Y
-26.9%
Cipher Pharmaceuticals
Market Cap: CA$327.3m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$12.47
7D
-13.0%
1Y
41.9%
MaxCyte
Market Cap: UK£176.5m
A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MXCT
UK£1.66
7D
-18.2%
1Y
-55.1%
Alpha Tau Medical
Market Cap: US$233.2m
A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
DRTS
US$2.83
7D
4.0%
1Y
6.8%
Third Harmonic Bio
Market Cap: US$232.4m
A biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases.
THRD
US$5.15
7D
0.2%
1Y
-60.1%
Phathom Pharmaceuticals
Market Cap: US$230.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.
PHAT
US$3.25
7D
35.4%
1Y
-68.8%
Bright Minds Biosciences
Market Cap: CA$322.0m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$45.71
7D
3.5%
1Y
3,096.5%
Canopy Growth
Market Cap: CA$317.9m
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
WEED
CA$1.98
7D
10.6%
1Y
-85.3%
Aquestive Therapeutics
Market Cap: US$227.5m
Operates as a pharmaceutical company in the United States and internationally.
AQST
US$2.22
7D
-18.7%
1Y
-31.1%
Lexicon Pharmaceuticals
Market Cap: US$227.3m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
LXRX
US$0.53
7D
-22.4%
1Y
-72.6%
Atea Pharmaceuticals
Market Cap: US$225.1m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.
AVIR
US$2.55
7D
-5.9%
1Y
-31.3%
Animalcare Group
Market Cap: UK£169.7m
Develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally.
ANCR
UK£2.46
7D
2.5%
1Y
9.3%
Optima Health
Market Cap: UK£168.7m
Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.
OPT
UK£1.90
7D
1.6%
1Y
n/a
Tactile Systems Technology
Market Cap: US$222.7m
A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
TCMD
US$9.58
7D
-0.6%
1Y
-30.0%
Rezolute
Market Cap: US$222.2m
A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.
RZLT
US$3.49
7D
-3.3%
1Y
31.7%
Neurogene
Market Cap: US$221.2m
A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.
NGNE
US$15.22
7D
9.8%
1Y
-54.7%
Monash IVF Group
Market Cap: AU$340.9m
Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.
MVF
AU$0.88
7D
8.0%
1Y
-40.9%
Astria Therapeutics
Market Cap: US$220.1m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
ATXS
US$3.97
7D
-10.2%
1Y
-57.2%
Aardvark Therapeutics
Market Cap: US$220.0m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$8.74
7D
-17.8%
1Y
n/a
Medical Facilities
Market Cap: CA$302.9m
Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.
DR
CA$15.34
7D
1.2%
1Y
29.3%
Solid Biosciences
Market Cap: US$216.2m
Develops therapies for neuromuscular and cardiac diseases in the United States.
SLDB
US$2.55
7D
-1.5%
1Y
-73.7%
Dimerix
Market Cap: AU$333.0m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.59
7D
-15.1%
1Y
76.1%
MediWound
Market Cap: US$215.3m
A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
MDWD
US$19.43
7D
8.8%
1Y
8.9%